Why the study?
Does polymer-free biolimus A9 drug-coated stent improve twelve-month outcomes in patients with acute coronary syndrome unsuitable for prolonged DAPT?
Does polymer-free biolimus A9 drug-coated stent improve twelve-month outcomes in patients with acute coronary syndrome unsuitable for prolonged DAPT?
Answers are grounded in this paper and cite their sources.
Polymer-free biolimus A9 drug-coated stents may offer a viable treatment option for ACS patients who cannot tolerate prolonged DAPT, though further studies are needed.
The outcomes of patients treated with polymer-free BA9 drug-coated stent who present with an ACS and who were deemed unsuitable for prolonged DAPT are encouraging. Further studies are warranted.
No takes yet. Share an insight, caveat, or question.
Kinnaird et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: